Design and synthesis of novel selective CDK9 inhibitors
With the findings in anticancer and antiretroviral research, it is strongly believed that CDK9 inhibition would be a useful therapeutic strategy in these fields. A number of pharmacological CDK inhibitors have been previously reported and are undergoing preclinical and clinical evaluation, but none...
Main Author: | Shi, Shenhua |
---|---|
Published: |
University of Nottingham
2011
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.603594 |
Similar Items
-
The development of novel thymidylate synthase inhibitors targeted to a-folate receptor overexpressing tumours
by: Theti, Davinder Singh
Published: (2002) -
Designing inhibitors of activator protein 1 based on the leucine zipper motif
by: Crooks, R. O.
Published: (2013) -
Tumour-selective depletion of thymidine and activity of raltitrexed
by: Graham, Claire L.
Published: (2004) -
Novel strategies for the development of biological therapeutics and diagnostics
by: Caswell, J. M.
Published: (2012) -
Direct selection and adoptive transfer of cytomegalovirus-specific cytotoxic T cells
by: Cobbold, Mark
Published: (2005)